Inotiv prelim Q4 revenue $137.5-138.5M; full year $512.5-513.5M; DSA awards up 60% YoY

Inotiv, Inc.

2025-FY EPS reported -$2.11 revenue$513,024,000

Preliminary Q4 FY2025 revenue $137.5-138.5M, improving over prior year; full year $512.5-513.5M.
DSA book-to-bill ~1.08x in Q4 and ~1.05x for FY2025; backlog $138.0M at Sept 30, 2025.
DSA contract awards in Q4 increased 60% year-over-year.
Full fiscal 2025 audited results expected in early December 2025.
CEO Robert Leasure Jr. to present at Jefferies Global Healthcare Conference Nov 18 at 6:00 AM ET.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.